Table 3.
Author | Year | Country | Population | M/F | RSBI | |||||
---|---|---|---|---|---|---|---|---|---|---|
Success | Failure | |||||||||
Mean | SD | N | Mean | SD | N | |||||
Abdelwahed et al. (13) | 2019 | Egypt | 65 | 40/25 | 79.58 | 20 | 51 | 102 | 17.07 | 14 |
Alam et al. (14) | 2022 | Bangladesh | 31 | 19/12 | 100.46 | 2.84 | 18 | 99 | 3.71 | 13 |
Elshazly et al. (15) | 2020 | Egypt | 62 | NR | 43.95 | 14 | 34 | 54 | 25.48 | 28 |
Eltrabili et al. (16) | 2019 | Egypt | 35 | 16/19 | 39 | 18 | 17 | 77 | 30 | 13 |
Farghaly et al. (17) | 2017 | Egypt | 54 | 31/23 | 58.59 | 26 | 40 | 51 | 20.59 | 14 |
Ferrari et al. (18) | 2014 | Italy | 46 | 34/12 | 70 | 20 | 29 | 126 | 30.71 | 17 |
Fossat et al. (19) | 2022 | France | 100 | NR | 56 | 26 | 91 | 56 | 28.3 | 9 |
Kaur et al. (20) | 2022 | India | 50 | NR | 46.61 | 18. | 31 | 105 | 7.93 | 19 |
Li et al. (21) | 2021 | China | 101 | 42/59 | 75.68 | 18. | 69 | 105 | 16.07 | 32 |
Lin et al. (22) | 2024 | China | 79 | 69/10 | 44.57 | 6. | 57 | 73 | 16.85 | 22 |
Osman et al. (23) | 2017 | Egypt | 68 | NR | 72.18 | 10 | 50 | 114 | 5.48 | 18 |
Palker et al. (24) | 2018 | USA | 73 | 37/36 | 45.9 | 19 | 53 | 75.5 | 57.4 | 20 |
Sabetian et al. (25) | 2024 | Iran | 50 | 39/11 | 38.24 | 7 | 26 | 120 | 16.86 | 24 |
Tenza-Lozano et al. (11) | 2018 | Spain | 69 | 43/26 | 31.35 | 17 | 44 | 40 | 18.86 | 25 |
Theerawit et al. (10) | 2018 | Thailand | 52 | 38/14 | 55.11 | 25 | 51 | 83 | 53.11 | 11 |